Higher blood levels of a specific ratio between two fats, called ceramides, may help identify people with Parkinson’s disease…
Articles by Michela Luciano, PhD
Alzheimer’s-related brain changes may not be a major contributor to earlier cognitive problems in people with Parkinson’s disease who…
Patients participating in a three-week digital intervention program designed to complement levodopa, the standard treatment for Parkinson’s disease, showed…
Specialists evaluating cognitive impairment in people with Parkinson’s disease rely on much more than the score from a commonly…
A pivotal clinical trial testing the light therapy device Celeste for Parkinson’s disease has wrapped up, with…
Topline results from a Phase 2 trial testing oral bezisterim as a first-line, stand-alone treatment for early Parkinson’s disease…
Vyalev, Abbvie‘s continuous under-the-skin infusion formulation of levodopa/carbidopa, reduces off time and eases motor and some nonmotor symptoms in…
A protein found in a common liverwort plant could be engineered to clear the toxic protein clumps associated with…
The weight loss commonly seen in Parkinson’s disease isn’t just about eating less. It’s about a fundamental shift in…
Six months of regular aerobic exercise can partially “normalize” disrupted brain communication in people with Parkinson’s disease, a new…